[Clinical evaluation of the use of diuretics in the ascitic phase of hepatic cirrhosis].
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000584:Amiloride / Q000627:therapeutic use; D001201:Ascites / Q000188:drug therapy* / Q000209:etiology; D002986:Clinical Trials as Topic; D004232:Diuretics / Q000627:therapeutic use*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000150:complications*; D008297:Male; D008875:Middle Aged; D013148:Spironolactone / Q000627:therapeutic use; D014223:Triamterene / Q000627:therapeutic use
D004232:Diuretics; D006852:Hydrochlorothiazide; D013148:Spironolactone; D000584:Amiloride; D005665:Furosemide; D014223:Triamterene
Valutazioni cliniche sull'uso dei diuretici nella cirrosi epatica in fase ascitica.